Dr. Kimball is CEO of Harvard Medical Faculty Physicians at Beth Israel Deaconess Hospital, as well as a practicing clinician, researcher and professor of dermatology at Harvard Medical School. She oversees more than 2,000 physicians and an $890 million organization, ensuring financial stability while advancing patient-centered care, particularly for underserved populations. A renowned expert in hidradenitis suppurativa, she has driven groundbreaking research and innovations to improve treatment for the debilitating skin disease. Beyond her role at Harvard Medical Faculty Physicians, she has played a pivotal role in legislative advocacy for healthcare access and was a key negotiator in the landmark cooperation agreement between Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center, both also based in Boston. Dr. Kimball is a champion for diversity in medicine, restructuring leadership recruitment to improve representation and implementing strategies to combat physician burnout. Her leadership is characterized by “mentored accountability,” fostering innovation and empowering those around her in the fields of healthcare, policy and academia.
